http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
AtriCure to Announce Fourth Quarter and Full Year 2024 Financial Results
-
AtriCure (ATRC) Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 202
-
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day
-
AtriCure to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
-
AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
-
AtriCure to Participate in the Stifel 2024 Healthcare Conference
-
AtriCure Reports Third Quarter 2024 Financial Results
-
AtriCure to Participate in the UBS Global Healthcare Conference
-
AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management
-
AtriCure to Announce Third Quarter 2024 Financial Results
-
AtriCure (ATRC) Receives CE-Mark for the EnCompass Clamp
-
AtriCure Receives CE-Mark for the EnCompass® Clamp
-
AtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip® FLEX-Mini™ Device
-
AtriCure (ATRC) Receives Expanded CE-Mark Indication for AtriClip® Devices for the Reduction of Stroke in Patients with Atrial Fibrillation
-
AtriCure Receives Expanded CE-Mark Indication for AtriClip® Devices for the Reduction of Stroke in Patients with Atrial Fibrillation
-
AtriCure Reports Second Quarter 2024 Financial Results
-
AtriCure to Participate in the Canaccord Genuity 44th Annual Global Growth Conference
-
AtriCure (ATRC) Receives Regulatory Approval to Sell AtriClip Devices in China
-
AtriCure Receives Regulatory Approval to Sell AtriClip® Devices in China
-
AtriCure to Announce Second Quarter 2024 Financial Results
-
AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
-
AtriCure Reports First Quarter 2024 Financial Results
-
AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference
-
AtriCure (ATRC) Announces Launch of the cryoSPHERE+
-
AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management
-
AtriCure to Announce First Quarter 2024 Financial Results
-
AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
-
AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results
-
AtriCure to Announce Fourth Quarter and Full Year 2023 Financial Results and Participate in 2024 BTIG Medical Technology Conference
-
AtriCure (ATRC) Reports Preliminary Results for Fourth Quarter and Full Year 2023, Provides Financial Outlook for 2024
-
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2023, Provides Financial Outlook for 2024
-
AtriCure Appoints Shlomi Nachman to the Board of Directors
-
AtriCure to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
-
AtriCure to Participate in the Piper Sandler 35th Annual Healthcare Conference
-
AtriCure Releases 2023 ESG Report
-
AtriCure Reports Third Quarter 2023 Financial Results
-
AtriCure to Participate in the Stifel 2023 Healthcare Conference
-
AtriCure to Announce Third Quarter 2023 Financial Results
-
AtriCure Reports Second Quarter 2023 Financial Results
-
AtriCure to Participate at Upcoming Investor Conferences
-
AtriCure to Announce Second Quarter 2023 Financial Results
-
AtriCure Reports First Quarter 2023 Financial Results
-
AtriCure to Participate in the 2023 Bank of America Health Care Conference and Host a Cryo Nerve Block Therapy Investor Education Webcast
-
AtriCure to Announce First Quarter 2023 Financial Results
-
AtriCure to Participate in the 22nd Annual Needham Virtual Healthcare Conference
-
AtriCure Reports Fourth Quarter 2022 and Full Year 2022 Financial Results
-
AtriCure to Participate in the Oppenheimer 33rd Annual Healthcare Conference
-
AtriCure Announces the First Patient Treated in the LeAAPS™ Clinical Trial
-
AtriCure to Announce Fourth Quarter and Full Year 2022 Financial Results and Participate in 2023 BTIG Medical Technology Conference
-
AtriCure (ATRC) Reports Preliminary Results for Q4 and FY22, Provides Financial Outlook for 2023

